Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Orphalan announces acquisition of Orphelia Pharma
Contributed by:
PR Newswire
Tags
Orphalan-Orphelia
More Like This
Norgine strengthens rare disease portfolio with acquisition of Theravia
Orphalan becomes the first European company to enter in China's Wilson Disease market
Oranda Therapeutics Announces Series A Funding Round to support its mission: to improve the lives of patients living with rare disease
Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies
Laprophan Completes the Acquisition of Rivopharm, Accelerating Its International Expansion Strategy
Norgine completes acquisition of Theravia
Sofinnova Partners Portfolio Company Amolyt Pharma to be Acquired by AstraZeneca
Pierre Fabre Laboratories and the EspeRare Foundation to be honored with the EURORDIS Company Award for Patient Engagement 2024, in their approach to co-developing a treatment for XLHED.
